Project Name：Imidafenacin 

Registration Classification：3.1

Formulations and specifications ：Tablets: 100mg. 

Indications：Urgency caused by overactive bladder , urinary frequency and incontinence

Original Research Company：Japan's Ono Pharmaceutical Co., Ltd. and Kyorin Pharmaceutical joint development. 

Progress ：Pharmaceutical Research in progress